Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-055174

General Counsel sold 3,200 shares at $35.25 ($112,800)

  • General Counsel acquired 3,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-07 Exercise or conversion : show line 1 in the form +3,200 $1.86 $5,952 4,486 D
2021-09-07 Sale : show line 2 in the form −3,200 $35.25 $112,800 1,286 D
Open-market sales · 3,200 sh · avg $35.25 · $112,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-07 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −3,200 107,666 D
Loading xslF345X03/doc4.xml…